Pfizer is testing a third Covid vaccine dose in young kids, delaying trial results

Norge Nyheter Nyheter

Pfizer is testing a third Covid vaccine dose in young kids, delaying trial results
Norge Siste Nytt,Norge Overskrifter
  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 51%

Pfizer and BioNTech are testing a third dose of a Covid vaccine for young children. The third dose is a lower amount than the adult doses.

Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia, criticized Pfizer's move, saying evidence to date shows that two doses of the vaccine still protect against severe disease.

"The goal is no longer just protection against serious illness but protection against infection," he said."That is not a goal we have for any other vaccine." But when it comes to kids getting three doses, Bogoch said,"I have no idea. As always, we cannot treat kids as little adults."Download thePfizer and BioNTech said Friday that an ongoing study for kids ages 6 months to under 5 years will now include a third dose containing 3 micrograms of mRNA given at least two months after the second dose.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NBCNewsHealth /  🏆 707. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Covid-19: Nisra records increase in Covid-related deathsCovid-19: Nisra records increase in Covid-related deathsThe agency's Covid deaths total, based on mentions of the virus on death certificates, is 3,937.
Les mer »

Pfizer is testing a 3rd COVID-19 vaccine dose in young kidsPfizer is testing a 3rd COVID-19 vaccine dose in young kidsPfizer and BioNTech are testing a third dose of their COVID-19 vaccine in an ongoing trial of children ages 6 months to under 5 years, the companies announced F
Les mer »

Pfizer files for full FDA approval of COVID-19 vaccine in adolescentsPfizer files for full FDA approval of COVID-19 vaccine in adolescentsPfizer Inc and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to include adolescents aged 12 to 15.
Les mer »

CDC recommends Pfizer, Moderna COVID-19 shots over J&J's | AP NewsCDC recommends Pfizer, Moderna COVID-19 shots over J&J's | AP NewsMost Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don't come with that risk and also appear more effective, said advisers to the Centers for Disease Control and Prevention.
Les mer »

Pfizer Testing Extra COVID-19 Vaccine Dose For Children Under 5Pfizer Testing Extra COVID-19 Vaccine Dose For Children Under 5The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn't have as strong an immune response as expected.
Les mer »



Render Time: 2025-03-23 02:51:17